COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 943: Articles 9421-9430  | Next

Cell-Mediated Immune Response after COVID 19 Vaccination in Patients with Inflammatory Bowel Disease
Caldera, F., Farraye, F., Necela, B., Cogen, D., Saha, S., Wald, A., Daoud, N., Chun, K., Grimes, I., Lutz, M., Swift, M. D., Virk, A., Bharucha, A. E., Patel, T., Gores, G. J., Chumsri, S., Hayney, M. S., Knuttson, K. L.
10.1101/2022.02.21.22271234 — Posted: 2022-02-23
Favourable vaccine-induced SARS-CoV-2 specific T cell response profile in patients undergoing immune-modifying therapies
QI, M., Le Bert, N., Chan, W., Tan, M., Hang, S. K., Hariharaputran, S., Sim, J. X. Y., Low, J., Ng, W. L., Wan, W. Y., Ang, T. L., Bertoletti, A., Salazar, E.
10.1101/2022.02.21.22271127 — Posted: 2022-02-23
Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study
Shehab, M., Alrashed, F., Abdullah, I., Alfadhli, A., Ali, H., Abu-farha, M., Channanath, A., Abubaker, J., Al-Mulla, F.
10.1101/2022.02.22.22271342 — Posted: 2022-02-23
Scottish COVID CAncer iMmunity Prevalence (SCCAMP) - a longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic
Purshouse, K., Thomson, J. P., Vallet, M., Alexander, L., Bonisteel, I., Brennan, M., Cameron, D., Figueroa, J., Furrie, E., Haig, P., Heck, M., McCaughan, H., Mitchell, P. D., McVicars, H., Primrose, L., Templeton, K., Wilson, N., Hall, P. S.
10.1101/2022.02.22.22271041 — Posted: 2022-02-23
Clinical severity of COVID-19 patients admitted to hospitals during the Omicron wave in South Africa
JASSAT, W., Abdool Karim, S., Mudara, C., Welch, R., Ozougwu, L., Groome, M., Govender, N., von Gottberg, A., Wolter, N., Wolmarans, M., Rousseau, P., Blumberg, L., Cohen, C.
10.1101/2022.02.22.21268475 — Posted: 2022-02-23
Early emergence phase of SARS-CoV-2 Delta variant in Florida
Cella, E., Ali, S., Schmedes, S. E., Rife, B., Marini, S., Salemi, M., Blanton, J., Azarian, T.
10.1101/2022.02.18.22271195 — Posted: 2022-02-22
Breakthrough SARS-CoV-2 infections in immune mediated disease patients undergoing B cell depleting therapy
Calabrese, C. M., Husni, E. M., Moss, B. M., Fernandez, A. J., Jin, Y., Kirchner, E., Calabrese, L. H.
10.1101/2022.02.21.22271289 — Posted: 2022-02-22
Psychological and financial impacts of COVID-19-related travel measures: An international cross-sectional study
McDermid, P., Sooppiyaragath, S., Craig, A., Sheel, M., Blazek, K., Talty, S., Seale, H.
10.1101/2022.02.21.22271299 — Posted: 2022-02-22
The efficacy, effectiveness and safety of SARS-CoV-2 disinfection methods (including ozone machines) in educational settings for children and young people
Edwards, D., Csontos, J. K., Gillen, E., Lewis, R., Cooper, A., Gal, M., Law, R.-J., Edwards, A.
10.1101/2022.02.21.22271281 — Posted: 2022-02-22
An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
Soto, J. A., Melo-Gonzalez, F., Gutierrez-Vera, C., Schultz, B. M., Berrios-Rojas, R. V., Rivera-Perez, D., Pina-Iturbe, A., Hoppe-Elsholz, G., Duarte, L. F., Vazquez, Y., Moreno-Tapia, D., Rios, M., Palacios, P. A., Garcia-Betancourt, R., Santibanez, A., Mendez, C., Diethelm-Varela, B., Astudillo, P., Calvo, M., Cardenas, A., Gonzalez, M., Goldsack, M., Gutierrez, V., Potin, M., Schilling, A., Tapia, L. I., Twele, L., Villena, R., Grifoni, A., Sette, A., Weiskopf, D., Fasce, R. A., Fernandez, J., Mora, J., Ramirez, E., Gaete-Argel, A., Acevedo, M., Valiente-Echeverria, F., Soto-Rifo, R., Retamal-Diaz, A., Munoz-Jofre, N., PedCoronaVac03CL Study Group, , Meng, X., Xin, Q., Alarcon-Bustamante, E., Gonzalez-Aramundiz, J. V., Le Corre, N., Javiera Alvarez, M., Gonzalez, P. A., Abarca, K., Perret, C., Carreno, L. J., Bueno, S. M., Kalergis, A. M.
10.1101/2022.02.15.22270973 — Posted: 2022-02-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).